Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

Curcumin utilizes the anti-inflammatory response pathway to protect the intestine against bacterial invasion

  • Cho, Jin Ah (Division of GI Cell Biology, Boston Children's Hospital) ;
  • Park, Eunmi (Department of Food and Nutrition, Hannam University)
  • Received : 2014.12.08
  • Accepted : 2014.12.26
  • Published : 2015.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

BACKGROUND/OBJECTIVES: Curcumin, a major component of the Curcuma species, contains antioxidant and anti-inflammatory properties. Although it was found to induce apoptosis in cancer cells, the functional role of curcumin as well as its molecular mechanism in anti-inflammatory response, particularly in intestinal cells, has been less investigated. The intestine epithelial barrier is the first barrier and the most important location for the substrate coming from the lumen of the gut. SUBJECTS/METHODS: We administered curcumin treatment in the human intestinal epithelial cell lines, T84 and Caco-2. We examined endoplasmic reticulum (ER) stress response by thapsigargin, qPCR of XBP1 and BiP, electrophysiology by wild-type cholera toxin in the cells. RESULTS: In this study, we showed that curcumin treatment reduces ER stress and thereby decreases inflammatory response in human intestinal epithelial cells. In addition, curcumin confers protection without damaging the membrane tight junction or actin skeleton change in intestine epithelial cells. Therefore, curcumin treatment protects the gut from bacterial invasion via reduction of ER stress and anti-inflammatory response in intestinal epithelial cells. CONCLUSIONS: Taken together, our data demonstrate the important role of curcumin in protecting the intestine by modulating ER stress and inflammatory response post intoxication.

Keywords

References

  1. Ron D, Hubbard SR. How IRE1 reacts to ER stress. Cell 2008;132:24-6. https://doi.org/10.1016/j.cell.2007.12.017
  2. Cho JA, Lee AH, Platzer B, Cross BC, Gardner BM, De Luca H, Luong P, Harding HP, Glimcher LH, Walter P, Fiebiger E, Ron D, Kagan JC, Lencer WI. The unfolded protein response element IRE1alpha senses bacterial proteins invading the ER to activate RIG-I and innate immune signaling. Cell Host Microbe 2013;13:558-69. https://doi.org/10.1016/j.chom.2013.03.011
  3. Ji JL, Huang XF, Zhu HL. Curcumin and its formulations: potential anti-cancer agents. Anticancer Agents Med Chem 2012;12:210-8. https://doi.org/10.2174/187152012800228733
  4. Kubota M, Shimizu M, Sakai H, Yasuda Y, Terakura D, Baba A, Ohno T, Tsurumi H, Tanaka T, Moriwaki H. Preventive effects of curcumin on the development of azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db obese mice. Nutr Cancer 2012;64:72-9. https://doi.org/10.1080/01635581.2012.630554
  5. Zeng Z, Zhan L, Liao H, Chen L, Lv X. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-kappaB signaling pathway. Planta Med 2013;79:102-9.
  6. Song WB, Wang YY, Meng FS, Zhang QH, Zeng JY, Xiao LP, Yu XP, Peng DD, Su L, Xiao B, Zhang ZS. Curcumin protects intestinal mucosal barrier function of rat enteritis via activation of MKP-1 and attenuation of p38 and NF-kappaB activation. PLoS One 2010;5: e12969. https://doi.org/10.1371/journal.pone.0012969
  7. Jian YT, Mai GF, Wang JD, Zhang YL, Luo RC, Fang YX. Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol 2005;11:1747-52. https://doi.org/10.3748/wjg.v11.i12.1747
  8. Zhang F, Altorki NK, Mestre JR, Subbaramaiah K, Dannenberg AJ. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 1999;20:445-51. https://doi.org/10.1093/carcin/20.3.445
  9. Zhang M, Deng C, Zheng J, Xia J, Sheng D. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. Int Immunopharmacol 2006;6:1233-42. https://doi.org/10.1016/j.intimp.2006.02.013
  10. Bounaama A, Djerdjouri B, Laroche-Clary A, Le Morvan V, Robert J. Short curcumin treatment modulates oxidative stress, arginase activity, aberrant crypt foci, and TGF-beta1 and HES-1 transcripts in 1,2-dimethylhydrazine-colon carcinogenesis in mice. Toxicology 2012;302:308-17. https://doi.org/10.1016/j.tox.2012.08.014
  11. Epstein J, Docena G, MacDonald TT, Sanderson IR. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br J Nutr 2010;103:824-32. https://doi.org/10.1017/S0007114509992510
  12. Moon DO, Jin CY, Lee JD, Choi YH, Ahn SC, Lee CM, Jeong SC, Park YM, Kim GY. Curcumin decreases binding of Shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-alpha and IL-1beta: suppression of p38, JNK and NF-kappaB p65 as potential targets. Biol Pharm Bull 2006;29:1470-5. https://doi.org/10.1248/bpb.29.1470
  13. Lencer WI, Delp C, Neutra MR, Madara JL. Mechanism of cholera toxin action on a polarized human intestinal epithelial cell line: role of vesicular traffic. J Cell Biol 1992;117:1197-209. https://doi.org/10.1083/jcb.117.6.1197
  14. Glimcher LH, Lindvall O, Aguirre V, Topalian SL, Musunuru K, Fauci AS. Translating research into therapies. Cell 2012;148:1077-8. https://doi.org/10.1016/j.cell.2012.02.036
  15. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and inflammation in the intestine. Cell 2010;140:859-70. https://doi.org/10.1016/j.cell.2010.01.023
  16. Heazlewood CK, Cook MC, Eri R, Price GR, Tauro SB, Taupin D, Thornton DJ, Png CW, Crockford TL, Cornall RJ, Adams R, Kato M, Nelms KA, Hong NA, Florin TH, Goodnow CC, McGuckin MA. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med 2008;5:e54. https://doi.org/10.1371/journal.pmed.0050054
  17. DiDonato JA, Mercurio F, Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev 2012;246:379-400. https://doi.org/10.1111/j.1600-065X.2012.01099.x
  18. Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol 2012;56:704-13. https://doi.org/10.1016/j.jhep.2011.09.020
  19. Karin M. Tracking the road from inflammation to cancer: the critical role of IkappaB kinase (IKK). Harvey Lect 2006-2007;102:133-51.
  20. Karin M. The IkappaB kinase-a bridge between inflammation and cancer. Cell Res 2008;18:334-42. https://doi.org/10.1038/cr.2008.30

Cited by

  1. Marine Diterpenoids as Potential Anti-Inflammatory Agents vol.2015, pp.1466-1861, 2015, https://doi.org/10.1155/2015/263543
  2. Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation vol.22, pp.1, 2016, https://doi.org/10.1097/MIB.0000000000000599
  3. Curcumin Protects Against Intestinal Origin Endotoxemia in Rat Liver Cirrhosis by Targeting PCSK9 vol.82, pp.3, 2017, https://doi.org/10.1111/1750-3841.13647
  4. Inhibition of EV71 by curcumin in intestinal epithelial cells vol.13, pp.1, 2018, https://doi.org/10.1371/journal.pone.0191617
  5. Clinical safety and efficacy of curcumin use for oral lichen planus: a systematic review pp.1471-1753, 2019, https://doi.org/10.1080/09546634.2018.1543849
  6. Connection between Systemic Inflammation and Neuroinflammation Underlies Neuroprotective Mechanism of Several Phytochemicals in Neurodegenerative Diseases vol.2018, pp.1942-0994, 2018, https://doi.org/10.1155/2018/1972714
  7. cell culture models and their potential to study the effect of food components on intestinal inflammation pp.1549-7852, 2018, https://doi.org/10.1080/10408398.2018.1506734
  8. Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data vol.32, pp.6, 2018, https://doi.org/10.1002/ptr.6037
  9. The Natural Occurring Compounds Targeting Endoplasmic Reticulum Stress vol.2016, pp.None, 2015, https://doi.org/10.1155/2016/7831282
  10. Data on the effects of anti-cancer drug of resveratrol in breast cancer cells, MDA-MB-231 cells vol.12, pp.None, 2015, https://doi.org/10.1016/j.dib.2017.03.029
  11. Curcumin as an Herbal Inhibitor Candidate Against HTLV-1 Protease vol.10, pp.1, 2015, https://doi.org/10.5812/jjhr.92813
  12. 3,3′-Diindolylmethane Improves Intestinal Permeability Dysfunction in Cultured Human Intestinal Cells and the Model Animal Caenorhabditis elegans vol.67, pp.33, 2019, https://doi.org/10.1021/acs.jafc.9b03039
  13. Curcumin Mitigates Immune-Induced Epithelial Barrier Dysfunction by Campylobacter jejuni vol.20, pp.19, 2015, https://doi.org/10.3390/ijms20194830
  14. Enteroids Derived From Inflammatory Bowel Disease Patients Display Dysregulated Endoplasmic Reticulum Stress Pathways, Leading to Differential Inflammatory Responses and Dendritic Cell Maturation vol.14, pp.7, 2015, https://doi.org/10.1093/ecco-jcc/jjz194
  15. Application of curcumin and its derivatives in tumor multidrug resistance vol.34, pp.10, 2015, https://doi.org/10.1002/ptr.6694